header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FIG-170608-32
Yan et al., 2017 - Tumor-associated neutrophils and macrophages promote gender disparity in hepatocellular carcinoma in zebrafish. Cancer research   77(6):1395-1407 Full text @ Cancer Res.
ADDITIONAL FIGURES
EXPRESSION / LABELING:
Genes:
Fish:
Condition:
Knockdown Reagents:
Anatomical Terms:
Stage: Day 6
PHENOTYPE:
Fish:
Condition:
Knockdown Reagents:
Observed In:
Stage: Day 6

Fig. 3 ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Gene Expression Details
Gene Antibody Fish Conditions Stage Anatomy Assay
csf1a gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage RTPCR
gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 neutrophil RTPCR
cxcl8a gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage RTPCR
cxcl18b gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage RTPCR
gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 neutrophil RTPCR
DsRed gz32Tg chemical treatment: doxycycline Day 6 liver IFL
gz32Tg + MO1-spi1b chemical treatment: doxycycline Day 6 liver IFL
gz32Tg + MO1-spi1b + MO3-csf3r chemical treatment: doxycycline Day 6 liver IFL
gz32Tg + MO3-csf3r chemical treatment: doxycycline Day 6 liver IFL
il1b gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage RTPCR
gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 neutrophil RTPCR
il12a gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage RTPCR
gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 neutrophil RTPCR
lyz gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 neutrophil RTPCR
mpeg1.1 gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage RTPCR
mpx gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 neutrophil RTPCR
nfkb2 gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage RTPCR
gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 neutrophil RTPCR
tnfa gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage RTPCR
gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 neutrophil RTPCR
Antibody Labeling Details No data available
Phenotype Details
Fish Conditions Stage Phenotype
gz32Tg chemical treatment: doxycycline Day 6 liver increased size, abnormal
gz32Tg + MO1-spi1b chemical treatment: doxycycline Day 6 liver size, ameliorated
gz32Tg + MO1-spi1b + MO3-csf3r chemical treatment: doxycycline Day 6 liver size, ameliorated
gz32Tg + MO3-csf3r chemical treatment: doxycycline Day 6 liver size, ameliorated
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 liver macrophage increased amount, abnormal
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage il12a expression decreased amount, abnormal
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage mpeg1.1 expression decreased amount, abnormal
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage csf1a expression increased amount, abnormal
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage cxcl8a expression increased amount, abnormal
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage nfkb2 expression increased amount, abnormal
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage cxcl18b expression increased amount, abnormal
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage il1b expression increased amount, abnormal
gz32Tg ; gl22Tg chemical treatment: doxycycline Day 6 macrophage tnfa expression increased amount, abnormal
gz32Tg ; gl22Tg + MO1-spi1b chemical treatment: doxycycline Day 6 liver macrophage amount, ameliorated
gz32Tg ; gl22Tg + MO1-spi1b + MO3-csf3r chemical treatment: doxycycline Day 6 liver macrophage amount, ameliorated
gz32Tg ; gl22Tg + MO3-csf3r chemical treatment: doxycycline Day 6 liver macrophage increased amount, abnormal
gz32Tg; nz50Tg chemical treatment: doxycycline Day 6 liver neutrophil increased amount, abnormal
Day 6 neutrophil mpx expression decreased amount, abnormal
Day 6 neutrophil tnfa expression decreased amount, abnormal
Day 6 neutrophil lyz expression decreased amount, abnormal
Day 6 neutrophil il12a expression decreased amount, abnormal
Day 6 neutrophil cxcl18b expression increased amount, abnormal
Day 6 neutrophil csf1a expression increased amount, abnormal
Day 6 neutrophil il1b expression increased amount, abnormal
Day 6 neutrophil nfkb2 expression increased amount, abnormal
gz32Tg; nz50Tg + MO1-spi1b chemical treatment: doxycycline Day 6 liver neutrophil increased amount, abnormal
gz32Tg; nz50Tg + MO1-spi1b + MO3-csf3r chemical treatment: doxycycline Day 6 liver neutrophil amount, ameliorated
gz32Tg; nz50Tg + MO3-csf3r chemical treatment: doxycycline Day 6 liver neutrophil amount, ameliorated
Full text @ Cancer Res.